Clinical trial
Phase I Study of High-Dose Cyclophosphamide and Total Body Irradiation With T…
NCT00017628 · Northwestern Memorial Hospital, Other · Completed
Key facts
| NCT number | NCT00017628 |
|---|---|
| Title | Phase I Study of High-Dose Cyclophosphamide and Total Body Irradiation With T Lymphocyte-Depleted Autologous Peripheral Blood Stem Cell or Bone Marrow Rescue in Patients With Multiple Sclerosis |
| Lead sponsor | Northwestern Memorial Hospital, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Multiple Sclerosis |
| Intervention type | Drug, Procedure |
| Interventions | cyclophosphamide, filgrastim, methylprednisolone, Autologous Stem Cell Transplantation |
| Enrollment | 20 |
| Start date | Apr 1, 2001 |
| First posted | Jun 6, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: